Cyclophosphamide treatment regulates the balance of functional/exhausted tumor-specific CD8+ T cells
An important question is how chemotherapy may (re-)activate tumor-specific immunity. In this study, we provide a phenotypic, functional and genomic analysis of tumor-specific CD8+ T cells in tumor (P815)-bearing mice, treated or not with cyclophosphamide. Our data show that chemotherapy favors the d...
Main Authors: | Aurélie Hanoteau, Coralie Henin, David Svec, Charlotte Bisilliat Donnet, Sébastien Denanglaire, Didier Colau, Pedro Romero, Oberdan Leo, Benoit Van den Eynde, Muriel Moser |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-08-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2017.1318234 |
Similar Items
-
Cyclophosphamide Regulates N6-Methyladenosine and m6A RNA Enzyme Levels in Human Granulosa Cells and in Ovaries of a Premature Ovarian Aging Mouse Model
by: Boxian Huang, et al.
Published: (2019-06-01) -
Cyclophosphamide in a Recalcitrant Case of Nekam’s Disease
by: Aishwarya Muddebihal, et al.
Published: (2023-07-01) -
Analysis of cyclophosphamide induced ovarian insufficiency and differentially expressed genes in rats
by: ZHANG Yu-lin, ZOU Heng, ZHANG Chan-yu
Published: (2022-08-01) -
Premature ovarian failure in systemic lupus erythematosus patients: is it related to cyclophosphamide treatment?
by: Rasha M Ghaleb, et al.
Published: (2019-01-01) -
Cyclophosphamide Versus Rituximab in Progressive Forms of Multiple Sclerosis
by: Masoud Etemadifar, et al.
Published: (2020-02-01)